microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases?
Sign Up to like & getrecommendations! Published in 2018 at "Thrombosis research"
DOI: 10.1016/j.thromres.2018.03.021
Abstract: MicroRNAs (miRNAs) are small endogenous RNAs that post-transcriptionally regulate gene expression. In the last few years, these molecules have been implicated in the regulation of haemostasis, and an increasing number of studies have investigated their… read more here.
Keywords: witnesses thromboembolic; thromboembolic diseases; haemostatic system; micrornas haemostatic ... See more keywords
Endovascular Therapy for Venous Thromboembolic Diseases.
Sign Up to like & getrecommendations! Published in 2021 at "Acta Cardiologica Sinica"
DOI: 10.6515/acs.202111_37(6).20210505b
Abstract: Thrombolytic therapy plays an important role in treating venous thromboembolic events in patients with unstable hemodynamics or compromised limb circulation. Standard catheter-directed thrombolysis requires a lower dosage of thrombolytic agents than systemic thrombolysis, thus lowering… read more here.
Keywords: venous thromboembolic; therapy; thrombolytic agents; thromboembolic diseases ... See more keywords